It wasn’t so long ago that I did a post explaining why after following the company for years, I finally bought a small amount of stock in the stem cell biotech, Advanced Cell Technology (ACT; symbol ACTC). In part it was motivated by my enthusiasm to see them publishing a paper, a very preliminary paper, …
Why Lanza and I sold ACT stock Read More »
The post Why Lanza and I sold ACT stock appeared first on The Niche.
